Onvitrelin ucalontide

Onvitrelin ucalontide is under investigation in clinical trial NCT01485848, EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer. Reference standards of Onvitrelin Ucalontide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Onvitrelin ucalontide
    [catalogue_number] => PA PEP 001233
    [category_ids] => ,114,
    [chemical_name] => 
    [weight] => 3317.01
    [form] => C163H243N43O32
    [cas] => 1174415-90-7
    [pslug] => 1174415-90-7-onvitrelin-ucalontide-papep001233
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA PEP 001233

Onvitrelin ucalontide


  • Catalogue No.:PA PEP 001233

  • CAS :

    1174415-90-7

  • Molecular Formula : C163H243N43O32

  • Molecular Weight : 3317.01

CPHI INDIA- 28, 30 November